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Summary
y/b cells were at least four timesmore frequent in lactating mouse mammary glands than among
T cells of the most proximal lymph nodes. Two-color staining of freshly isolated T cells and
a study of clonally expressed 'y/6 receptors on hybridomas further revealed that the mammary
-ylb population is heterogeneous, including at least three different subsets, among them cells
expressing Vy5, Vy4 together with V64, or none of these V regions .
Antigen receptors on T lymphocytes are heterodimeric mol-
ecules, composed of either a and /3 or y and S chains .
Lymphocytes expressing y/6 antigen receptors constitute a
minor population in lymphoid tissue but are a major popu-
lation within epidermal, gastrointestinal, and vaginouterine
epithelia (1-3) . Based on the limited diversity of their an-
tigen receptors and the localization of -ylb cells in these
epithelia, it has been proposed that yld T cells are involved
in immunological surveillance of epithelia separating the ex-
ternal environment from the internal milieu (4) . Here, we
have examinedmammary glands, another epithelial organ in
contact with the external environment, in terms of y/6 T
cell content andTCRy/6 expression . Lactating mammary
glands were selected for study because local immunity and
epithelial surface area areboth increased in the mammary gland
during lactation (5) . TCR-y/6-bearing cells are present in
lactating murine mammary tissue at a frequency at least four
times greater than in lymph nodes draining that tissue and
can be classified into three subsets based onTCR expression .
Materials and Methods
mAbs.
￿
H57-597.2 (anti-pan TCR-ot/B), GL2 (anti-V64), and
GL3 (anti-panTCRy/6) were generated in the laboratories ofR .
Kubo (6) andL. Lefrancois (2), respectively. 145-2C11 (anti-CD3
e chain), 403A.10 (anti-pan TCR-y/6) and 536 (anti*y5) were
gifts ofJ . Bluestone (7), O. Kanagawa (8), and J. Allison (9), respec-
tively.
CellPreparation .
￿
Mammary gland tissue from lactating C57B1/
10, C57B1/6, or C3H/HeJ mice (The Jackson Laboratory, Bar
Harbor, ME), 1-7 d post-partuni, was dissected from the subcuta-
neous tissue plane of the abdominal fat pads. Axillary, brachial,
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andepigastriclymph nodes were removed from the mammary tissue.
Cell suspensions were nylon wool purified . Nylon wool-nonad-
herent cells were activated with conA (5 wg/ml) or surface-bound,
crosslinking mAb 145-2C11 .
T Cell Hybridoma Production and Analysis.
￿
1-3 x 106 nylon
wool-purified mammary cells or epigastric lymph node cells were
fused with 2 x 10' BW5147 ct- / ;8- cells (10) . The hybridomas
as well as the purified fresh mammary and lymph node cells were
stained with the above mAbs as previously described (6), followed
by one- or two-color cytofluorimetric analysis.
SDS-PAGE GelAnalysis ofHybridoma TCR .
￿
Hybridomas were
cell surface labeled with hzs, solubilized with digitonin, and their
TCR protein chains were separated as previously described (11) .
Amplification and Sequencing ofHybridoma TCRcDNAs .
￿
cDNA
fragments were prepared and amplified as described (12) . In-frame
transcripts were found with the following primers: Cyl (internal),
GGGGAAATGTCTGCATCAAG ; Cyl (external), GAAGGAGG-
GAAAATAGTGGG; Vy4 (external), GCAACCTGAAATATC-
AATTT ; CS (internal), TGGTTTGGCCGGAGGCTGGC ; Cb
(external), TGTTCCATTTTTCATGATGA ; C64 (external),CAG
ACAGTGTCTCAGCCTCAG. Single-stranded cDNA was se-
quenced using dideoxy-nucleotides (13) .
Results and Discussion
Mammary TCR-ylabearing Lymphocytes .
￿
As shown in two
of five replicate experiments with lactating C57B1/10 and
C3H/HeJ mice, y/b cells inmammary T lymphocyte prepa-
rations were at least four times more frequent than in T cell
preparations from mammary-associated lymph nodes (Table
1) . Notably, relative frequencies ofmammary y/b cells were
more variable (range, 8.4-31%) than frequencies oflymph
node ylb cells (range, 1.4-3.0% among epigastric and
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Volume 172 October 1990 1263-1266Two-color analysis was done using nylon wool-enrichedT cells from C57BI/10 or C3H/HeJ mice . The above staining patterns were detected with
the following mAbs : 145-2C11 for CD3, GL2 for VS4, and 536 for Vy5. TCR-7/6 staining of cells from C3H/HeJ and C57BI/10 was done
with mAbs GL3 and 403A.10, respectively .
Numbers in parentheses represent total numbers of stained cells counted for each mAb staining pattern and are independent of other parenthesized
numbers .
t Percent a/S+ T cells are approximated as the number of CD3 " cells that are not y/S cells .
1.2-3.7% among brachial/axillary nodeT cells) (not shown) .
This variation could be due to the smaller sample sizes of
mammary T cells or might actually reflect physiological
changes in the dynamic mammary tissues .
To characterize mammary y/S T cells further, two V re-
gion-specificmAbs (mAb 536, antiVy5 ; andmAb GL2, anti-
V64) were used for two-color staining in combination with
anti-CD3 (mAb 145-2C11) or panspecific anti-mouse y/S
(mAbs GL3 and 403A.10) antibodies . Unlike TCR-y/S-
bearing lymphocytes in mouse epidermis (1), only -20%
of mammary y/S cells expressed Vy5 . In addition, -10%
of mammary y/S cells expressed VS4, a V gene that also is
expressed by gut epithelium-associated lymphocytes (2) . Thus,
y/S populations in the lactating mammary gland are hetero-
geneous and can be divided into three subsets expressing
different TCRs based on the staining experiments and fur-
ther evidence outlined below. Whether the composition of
mammary y/S cells differs fromy/S cells in the nearest lymph
nodes, which presumably drain the mammary tissues, is not
clear. Nevertheless, the higher frequency of y/S cells among
mammary T lymphocytes suggests that y/6 cells specifically
home to or expand in this organ .
VS4+ y/d Cells .
￿
Because of the availability of anti-V64
mAb, further experiments focused on the VS4+ subset in
lactating mammary tissue. An attempt wasmade to generate
mammary y/S T cell hybridomas, sinceVS4+ cells could be
selected for clonal receptor characterization . In the first fu-
sion experiment with freshly prepared cells from lactating
C57BI/10 mammary glands, 41 hybridomas were generated,
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but in three repetitive fusions, no further hybridomas were
obtained . As mammary fusions were usually carried out in
parallel with lymph node cell fusions where no such varia-
tion was observed, experimental conditions were not likely
Figure 1 .
￿
Analysis ofTCR y andS chains from mammary-derived T
cell hybridomas. Mammary-derived hybridomas, 56BAM-15, -34, -40, and
-45, along with control fetal andnewborn thymus-derived hybridomas,
were 1125 labeled and lysed with digitonin . 145-2C11-precipitated mem-
brane proteins were separated by a two-step nonreduced-reduced SDS-
PAGE procedure (11) . Apparent molecular masses of mammary 'r and S
chains were -37 and -47 kD, respectively.
Table 1. Cytofluorometric Characterization ofTCR-y/b-bearing Mammary Cell Populations
TCR Percent and no . of stained cells
components
Mouse stained (two- Mammary Epigastric Axillary/
strain color staining) gland nodes brachial nodes
C3H/HeJ CD3 84 (15,333)" 87 (86,584) 89 (177,120)
a//3$ 91 (13,993) 99 (85,389) 99 (174,939)
CD3 and 7/6 8.7 (1,340) 1 .4 (1,195) 1.2 (2,181)
CD3 and V64 0.8 (106) 0.3 (252) 0.1 (165)
y/6 and V64 8.9 (152) 13 (375) 15 (430)
C57BI/10 CD3 80 (7,285) 97 (6,416) ND
cc/13t 92 (6,676) 98 (6,287)
CD3 and y/6 8.4 (609) 2.0 (129)
CD3 and Vy5 1.7 (136) 1 .0 (70)
y/6 and V64 9.8 (156) 25 (45)Mammary hybridomas have functional sequences identical to those of the fetal thymocyte hybridoma, 33BTE-67.1. As in the fetal thymus-derived
hybridoma, and in contrast to the AKR thymoma, BW5147 (13), N-region nucleotides are missing. The cytosine in the V64-DS2junctions appears
to represent a palindromic nucleotide (15).
' Published sequence (13) .
to be the reason for the variable outcome of the mammary
fusions. Two further mammary cell fusions were carried out
after normal T cells had been activated (see Materials and
Methods). Again, the number ofgenerated hybridomas varied
greatly. Of82 TCRbearing hybridomas from six experiments,
40 were TCR-,y/3' . 39 of these (all derived from the first
fusion, designated 56BAM) were reactive with the V64-specific
mAb but not with the Vy5-specific reagent, and one cell
did not stain with either antibody.
Ills-labeled receptors of four randomly chosen VS4+
mammary hybridomas were further analyzed by two-step SDS-
PAGE and compared with receptors of previously character-
ized TCR-y/6-bearing hybridomas (Fig. 1). y and S chains
of all mammary hybridomas were found to have identical ap-
parent molecular masses and to comigrate with the receptor
proteins of a V64/Vy4+, C57B1/6 day 16 fetal thymus-de-
rived hybridoma, 33BTE-67.1 (9). Thus, gel electrophoresis
confirmed the results of the staining experiments and sug-
gested Vy4JCy1 as part of the surface-expressed y/S het-
erodimer.
The sequence ofthe PCRamplified single-stranded cDNA
from the same four mammary hybridomas revealed functional
rearrangements ofboth VS4 and Vy4 genes (Table 2). func-
tional sequences ofthese hybridomas were found to be iden-
tical to each other and to those of 33BTE-67.1. The Vy4
sequence also appears to be shared by some vaginouterine cells
(3). In contrast to the nonfunctional expressed Vy4 gene of
the fusion line, BW5147 (13), N-region nucleotides were ab-
sent. That the original mammary fusion was contaminated
with the fetal thymus hybridoma is excluded by a molecular
mass polymorphism of y chains between C57B1/6 (the source
for 33BTE-67.1) and C57B1/10 mice (the source for the mam-
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mary hybridomas), which has been observed by others (14)
and is evident in Fig. 1. Because we were unable to detect
differences between the mammary hybridomas by prelimi-
nary Southern blot analyses ofTCRa gene loci (not shown),
and since all VS4/Vy4+ hybridomas were generated in the
same fusion experiment, the possibility remains that they/S
receptors analyzed were all derived from one clonally expanded
cell.
The data in this report document the existence of a TCR-
y/a-bearing lymphocyte population in the lactating murine
mammary gland. Unlike epidermal and vaginouterine y/S
cells (1, 3), this population is heterogeneous, as shown by
analyses ofboth mixed cellpopulations and individual clones.
The heterogeneity is likely to correspond to the greater com-
plexity of mammary tissues.
The VS4+ subset of mammary y/S cells appears note-
worthy both because of its anatomical location and because
ofthe possibility that these cells are selectively activated and/or
clonally expanded during lactation. Whether the V64/
Vy4+ hybridomas that were generated in one fusion are
fully representative of this subset remains uncertain. An al-
ternative possibility is that the hybridomas represent a patho-
logical process in one mouse, e.g., clonal expansion after an
immune response within mammary tissues or neoplastic trans-
formation of a VS4+ clone. Nevertheless, both V gene usage
and lack of N-region additions in the VS4/Vy4+ hybrid-
omas suggest that they are, like epidermal y/S cells, derived
from developmentally early y/S precursors. VS4+ lympho-
cytes in the mammary gland could be yet another example
of a uniform and perhaps functionally specialized peripheral
y/S population.
Table 2. y and 6 functional Sequences from Vy4'/Vo54' Mammary Hybridoms
DNA source V64 P? DS2 N JSi
Germline . . .ATG GAG CG. . . . . .ATCGGAGGGATACGAG. . . . . .CT ACC GA. . .
56BAM-15, -34,
-40, -45 . . .ATG GAG CG C GGGATACGAG CT ACC GA. . .
33BTE-67.1 . . .ATG GAG CG C GGGATACGAG CT ACC GA. . .
Vy4 N Jy1
Germline . . .GT TCC TAC GGC TAA AG. . . . . .AT AGC TCA G. . .
BW5147* . . .GT TCC TAC GGC T AAAGGAGAGAGG AGC TCA G. . .
56BAM-15, -34,
-40, -45 . . .GT TCC TAC GGC T AT AGC TCA G. . .
33BTE-67.1 . . .GT TCC TAC GGC T AT AGC TCA G. . .We thankDr.WilliamWeston forcritical comments andMary Petersonforsecretarial assistance in preparing
this manuscript.
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